市场调查报告书
商品编码
1492344
大麻酚市场:按产品类型、来源、应用、分销管道划分 - 全球预测 2024-2030Cannabinol Market by Product Type (Capsules & Softgels, Edibles, Oils & Tinctures), Source (Non-Organic, Organic), Application, Distribution Channel - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年大麻酚市场规模为86.9亿美元,预计2024年将达到95.7亿美元,2030年将达到172.4亿美元,复合年增长率为10.28%。
大麻酚是大麻植物中天然存在的化合物,是由四氢大麻酚 (THC) 分解产生的,四氢大麻酚是大麻中发现的化合物,常见于较旧的大麻产品中。大麻酚 (CBN) 市场专注于用于治疗和健康应用的 CBN 注入产品的生产、分销和销售,例如药品、健康产品、化妆品和营养食品。该市场迎合各种最终用户的需求,包括医疗保健提供者、健康爱好者和寻求自然缓解选择的普通消费者。社会对 CBN 潜在治疗作用的认识不断提高,以及对自然疗法的兴趣日益浓厚,正在推动全球对大麻酚的需求。然而,高昂的生产成本、市场上仿冒品氮化硼产品的存在以及产品召回的普遍存在阻碍了市场的成长。此外,增加对研究和创新的投资,包括证明治疗功效的大规模临床试验、产品输送机制的进步以及永续的培养和提取方法,将推动CBN 市场的显着增长,其增长潜力使其成为令人兴奋的市场。
主要市场统计 | |
---|---|
基准年[2023] | 86.9亿美元 |
预测年份 [2024] | 95.7亿美元 |
预测年份 [2030] | 172.4亿美元 |
复合年增长率(%) | 10.28% |
区域洞察
全球大麻酚市场呈现不同地区的不同法规环境和消费者利益。在北美和南美,特别是美国,随着消费者对立方氮化硼作为助眠剂和放鬆产品的成分越来越感兴趣,该市场正在快速成长。该地区的大麻和医疗保健法规正在不断发展,促进了充满活力的市场环境。凭藉大麻合法化框架,加拿大为大麻素研究和商业活动创造了有利的环境,推动了消费者对含立方氮化硼健康产品的强烈偏好。美国和加拿大的消费者对健康和天然保健产品有着浓厚的兴趣,推动了高需求和显着的市场活动。在欧洲、中东和非洲地区,消费者的需求和行为因监管环境而异。在健康趋势的推动下,欧洲对 CBN 的兴趣日益浓厚。在中东,由于严格的监管,市场活动受到限制,而在非洲,兴趣主要集中在南非。在亚太地区,特别是在中国、日本和印度等国家,法律体制的逐步变化和意识的提高正在推动大麻酚的需求。对大麻酚健康益处的研究和开发正在推动该地区对大麻酚的需求。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在大麻酚市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对大麻酚市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对大麻酚市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[194 Pages Report] The Cannabinol Market size was estimated at USD 8.69 billion in 2023 and expected to reach USD 9.57 billion in 2024, at a CAGR 10.28% to reach USD 17.24 billion by 2030.
Cannabinol is a naturally occurring compound in the cannabis plant that is created as a result of the degradation of tetrahydrocannabinol (THC), the compound in cannabis, and is typically present in older cannabis products. The cannabinol (CBN) market is focused on producing, distributing, and selling CBN-infused products aimed at therapeutic and wellness applications, including pharmaceuticals, wellness products, cosmetics, and nutraceuticals. The market caters to various end-users, such as healthcare providers, wellness enthusiasts, and everyday consumers seeking natural relief options. The increasing public awareness of CBN's potential therapeutic benefits and the rising interest in natural therapies drive the global demand for cannabinol. However, high production costs, the presence of counterfeit CBN products in the market, and the prevalence of product recalls hinder market growth. Moreover, with increased investment in research and innovation, including extensive clinical trials to substantiate therapeutic claims, advancements in product delivery mechanisms, and sustainable cultivation and extraction practices, the CBN market has substantial growth potential, making it a noteworthy sector within wellness and pharmaceuticals.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.69 billion |
Estimated Year [2024] | USD 9.57 billion |
Forecast Year [2030] | USD 17.24 billion |
CAGR (%) | 10.28% |
Regional Insights
The global cannabinol market showcases diverse regulatory environments and consumer interests across different regions. In the Americas, particularly the United States, the market is burgeoning with growing consumer interest in CBN as a component of sleep aids and relaxation products, propelled by a significant number of patents and robust investment in research and product development. The evolving regulations regarding cannabis and healthcare in the region contribute to the dynamic market landscape. Canada, with its legalized cannabis framework, fosters a conducive environment for cannabinoid research and commercial activities, driving a strong consumer preference for wellness products containing CBN. Consumers in the U.S. and Canada have a strong interest in wellness and natural health products, driving high demand and significant market activities. In EMEA, consumer needs and behaviors vary widely depending on the regulatory landscape. Europe shows a growing interest in CBN, driven by the wellness trend. The Middle East displays limited market activities due to strict regulations, while Africa shows nascent interest, with actions concentrated mainly in South Africa. In Asia Pacific, particularly in countries includin China, Japan, and India, the gradual changes in legal frameworks and increasing awareness increase the demand for cannabinol. Research and development initiatives regarding the health benefits of cannabinol within the region drive the demand for cannabinol.
Market Insights
The market dynamics represent an ever-changing landscape of the Cannabinol Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cannabinol Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cannabinol Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
CV Sciences Expands PlusCBD Pet Product Line with New Pet Chews
CV Sciences, Inc. announced the expansion of its PlusCBD pet product offerings with the introduction of new pet chews. This addition aims to cater to the growing demand for natural pet supplements that support overall wellness. These new products support the company's commitment to improving the quality of life for pets through scientifically backed, high-quality CBD solutions. [Published On: 2024-03-26]
Launch of Synthetic CBD by Healthcare Firm Marks Significant Advancement in Epilepsy Treatment
Akumentis Healthcare introduced a synthetic form of CBD targeted at managing epilepsy, marking a noteworthy innovation in medical treatments. The launch emphasizes the increasing acceptance and integration of cannabinoid-based therapies in mainstream medicine, offering new hope for patients afflicted with seizure disorders. [Published On: 2024-01-11]
Zenara Receives Approval for Cannabidiol to Treat Neurological Disorders
Zenara received regulatory approval for its cannabidiol product, which is aimed at treating various neurological disorders. This decision represents a significant medical and pharmaceutical industry advance, opening doors for new therapeutic options for patients with neurological conditions. This development emphasizes the growing acceptance and integration of cannabinoid-based treatments in mainstream healthcare. [Published On: 2023-05-15]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cannabinol Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cannabinol Market, highlighting leading vendors and their innovative profiles. These include AURORA CANNABIS INC., CHARLOTTE'S WEB, INC., CV Sciences, Inc., Diamond CBD, Elixinol Wellness Limited, ENDOCA., Etz Hayim Holdings, SPC, Folium Biosciences Europe B.V., Gaia Botanicals, LLC, Gaia Herbs, Inc., Green Roads, High Labs International Inc., Isodiol International Inc., Medical Marijuana, Inc., Medterra CBD, LLC, NuLeaf Naturals, LLC, PharmaHemp d.o.o., and Shaman Botanicals LLC.
Market Segmentation & Coverage